|
|
Volumn 67, Issue 3, 2006, Pages 544-545
|
|
Use of serum prolactin in diagnosing epileptic seizures: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology [5]
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID A RECEPTOR;
ANTICONVULSIVE AGENT;
METOCLOPRAMIDE;
PROLACTIN;
AMYGDALOID NUCLEUS;
BRAIN REGION;
CLINICAL FEATURE;
COMPLEX PARTIAL SEIZURE;
DEPRESSION;
DIAGNOSTIC PROCEDURE;
DIFFERENTIAL DIAGNOSIS;
ELECTRIC ACTIVITY;
ELECTROCONVULSIVE THERAPY;
ELECTROENCEPHALOGRAM;
EPILEPTIC STATE;
GRAND MAL SEIZURE;
HIPPOCAMPUS;
HUMAN;
HYPOTHALAMUS;
HYPOTHESIS;
LETTER;
NERVE CELL;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
SEIZURE;
TONIC CLONIC SEIZURE;
BIOLOGICAL MARKERS;
EPILEPSY;
HUMANS;
LABORATORY TECHNIQUES AND PROCEDURES;
NEUROLOGY;
PROLACTIN;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
|
|
EID: 33747074885
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000234968.40364.31 Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
